INTERNATIONAL PATENT: ADARX PHARMACEUTICALS, INC. FILES APPLICATION FOR "NUCLEOSIDE-DERIVED LIPIDS FOR DRUG DELIVERY"

GENEVA, July 10 -- ADARX PHARMACEUTICALS, INC. (5871 Oberlin DriveSuite 200San Diego, CA 92121) filed a patent application (PCT/US2024/061878) for "NUCLEOSIDE-DERIVED LIPIDS FOR DRUG DELIVERY" on Dec 24, 2024. With publication no. WO/2025/144872, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Zhen (c/o ADARx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121), ZHU, Rui (c/o ADARx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121), FONG, Kin (c/o ADARx Pharmaceuticals, Inc.5871 O...